| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heme Oxygenase-1 | 15 | 2020 | 381 | 4.220 |
Why?
|
| Heme | 8 | 2023 | 307 | 4.060 |
Why?
|
| Carbon Monoxide | 17 | 2020 | 531 | 3.800 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2019 | 167 | 1.290 |
Why?
|
| Macrophages | 12 | 2020 | 5655 | 1.270 |
Why?
|
| Hemopexin | 2 | 2023 | 33 | 0.990 |
Why?
|
| Cyclin A | 3 | 2008 | 60 | 0.920 |
Why?
|
| Membrane Proteins | 7 | 2020 | 7880 | 0.890 |
Why?
|
| Biliverdine | 5 | 2020 | 29 | 0.890 |
Why?
|
| Cell Proliferation | 15 | 2020 | 10481 | 0.850 |
Why?
|
| G-Quadruplexes | 2 | 2021 | 162 | 0.830 |
Why?
|
| Prostatic Neoplasms | 9 | 2022 | 11124 | 0.790 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2019 | 90 | 0.790 |
Why?
|
| Hemolysis | 1 | 2023 | 420 | 0.780 |
Why?
|
| Mycobacterium bovis | 1 | 2021 | 150 | 0.760 |
Why?
|
| Cell Fractionation | 1 | 2021 | 252 | 0.760 |
Why?
|
| Colorimetry | 1 | 2021 | 147 | 0.750 |
Why?
|
| Chalcones | 2 | 2016 | 28 | 0.700 |
Why?
|
| Complement C5a | 1 | 2019 | 107 | 0.670 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2019 | 91 | 0.660 |
Why?
|
| Inflammation | 6 | 2023 | 10638 | 0.600 |
Why?
|
| Immunity | 2 | 2021 | 1012 | 0.590 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 424 | 0.550 |
Why?
|
| Stathmin | 1 | 2016 | 71 | 0.540 |
Why?
|
| Chemotaxis | 1 | 2019 | 607 | 0.540 |
Why?
|
| Escherichia coli Infections | 1 | 2020 | 532 | 0.540 |
Why?
|
| Histones | 3 | 2015 | 2599 | 0.530 |
Why?
|
| Myeloid Cells | 2 | 2017 | 810 | 0.510 |
Why?
|
| Chemokines | 1 | 2019 | 970 | 0.490 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2011 | 689 | 0.480 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2014 | 32 | 0.480 |
Why?
|
| DNA Damage | 2 | 2021 | 2432 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 2503 | 0.470 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 111 | 0.460 |
Why?
|
| Endometriosis | 1 | 2021 | 839 | 0.450 |
Why?
|
| Blood Coagulation Disorders | 1 | 2015 | 337 | 0.430 |
Why?
|
| Nitric Oxide | 4 | 2011 | 2132 | 0.430 |
Why?
|
| DNA | 3 | 2020 | 7301 | 0.420 |
Why?
|
| Nucleosomes | 1 | 2015 | 494 | 0.410 |
Why?
|
| Prostate | 1 | 2020 | 1774 | 0.400 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1889 | 0.390 |
Why?
|
| Cell Line, Tumor | 13 | 2021 | 16689 | 0.390 |
Why?
|
| Bilirubin | 3 | 2020 | 425 | 0.380 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 3586 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2014 | 546 | 0.370 |
Why?
|
| Vascular System Injuries | 1 | 2014 | 250 | 0.370 |
Why?
|
| Laminin | 2 | 2014 | 419 | 0.350 |
Why?
|
| Inflammasomes | 1 | 2014 | 495 | 0.350 |
Why?
|
| Blood Coagulation | 1 | 2015 | 1127 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2008 | 3508 | 0.350 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 96 | 0.340 |
Why?
|
| Animals | 33 | 2023 | 168757 | 0.340 |
Why?
|
| Signal Transduction | 12 | 2021 | 23403 | 0.340 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2727 | 0.330 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2009 | 2938 | 0.330 |
Why?
|
| Mice | 22 | 2023 | 81183 | 0.330 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 144 | 0.330 |
Why?
|
| Cystatin C | 1 | 2009 | 250 | 0.320 |
Why?
|
| Tuberculosis | 1 | 2021 | 1912 | 0.320 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 565 | 0.320 |
Why?
|
| Cell Nucleus | 2 | 2020 | 2969 | 0.310 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 323 | 0.310 |
Why?
|
| Apoptosis | 9 | 2021 | 9727 | 0.310 |
Why?
|
| Neoplasm Metastasis | 3 | 2020 | 4851 | 0.300 |
Why?
|
| Indoles | 1 | 2016 | 1839 | 0.300 |
Why?
|
| Cell Cycle | 3 | 2020 | 2967 | 0.300 |
Why?
|
| Collagen Type I | 1 | 2010 | 592 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 9 | 2020 | 21827 | 0.290 |
Why?
|
| Mice, Knockout | 7 | 2023 | 14557 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1213 | 0.280 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 9734 | 0.280 |
Why?
|
| Receptors, Androgen | 2 | 2009 | 1058 | 0.280 |
Why?
|
| Immunity, Innate | 2 | 2015 | 2958 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 8428 | 0.270 |
Why?
|
| Bone Marrow Transplantation | 2 | 2014 | 2765 | 0.270 |
Why?
|
| Endothelial Cells | 4 | 2014 | 3479 | 0.270 |
Why?
|
| Neoplasms | 4 | 2021 | 21683 | 0.250 |
Why?
|
| Androgens | 2 | 2010 | 1281 | 0.250 |
Why?
|
| Camptothecin | 1 | 2008 | 576 | 0.250 |
Why?
|
| Osteoblasts | 1 | 2010 | 1166 | 0.240 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 12072 | 0.240 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 624 | 0.240 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 13102 | 0.230 |
Why?
|
| Cyclin A1 | 3 | 2008 | 11 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 1526 | 0.210 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2899 | 0.210 |
Why?
|
| DNA Repair | 1 | 2011 | 2046 | 0.210 |
Why?
|
| Doxorubicin | 2 | 2023 | 2234 | 0.200 |
Why?
|
| Aorta | 1 | 2010 | 2061 | 0.200 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 972 | 0.200 |
Why?
|
| Cells, Immobilized | 1 | 2021 | 36 | 0.200 |
Why?
|
| Cell Membrane | 2 | 2021 | 3748 | 0.200 |
Why?
|
| Administration, Inhalation | 2 | 2014 | 1105 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 2849 | 0.190 |
Why?
|
| Endothelium, Vascular | 2 | 2010 | 4456 | 0.180 |
Why?
|
| Coenzyme A Ligases | 1 | 2020 | 43 | 0.180 |
Why?
|
| Cell Differentiation | 2 | 2015 | 11483 | 0.180 |
Why?
|
| Homeostasis | 2 | 2008 | 3340 | 0.180 |
Why?
|
| Calcium | 2 | 2010 | 5756 | 0.180 |
Why?
|
| Cells, Cultured | 8 | 2016 | 19229 | 0.180 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3462 | 0.180 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 336 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 3616 | 0.170 |
Why?
|
| Humans | 39 | 2023 | 744343 | 0.170 |
Why?
|
| BCG Vaccine | 1 | 2021 | 369 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2008 | 3200 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 713 | 0.150 |
Why?
|
| Phosphorylation | 5 | 2016 | 8436 | 0.150 |
Why?
|
| Metribolone | 2 | 2008 | 13 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2109 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3386 | 0.150 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2009 | 472 | 0.140 |
Why?
|
| Transfection | 2 | 2019 | 5892 | 0.140 |
Why?
|
| Cell Movement | 4 | 2014 | 5217 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 705 | 0.130 |
Why?
|
| Escherichia coli | 2 | 2020 | 4217 | 0.130 |
Why?
|
| Disease Progression | 3 | 2020 | 13284 | 0.130 |
Why?
|
| Colon | 1 | 2023 | 1772 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 987 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2008 | 4217 | 0.130 |
Why?
|
| Immunoblotting | 2 | 2008 | 1682 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 480 | 0.120 |
Why?
|
| Drug Synergism | 2 | 2021 | 1792 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 489 | 0.120 |
Why?
|
| Hemeproteins | 1 | 2014 | 62 | 0.120 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 87 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.120 |
Why?
|
| Retinoblastoma Protein | 2 | 2010 | 704 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9648 | 0.120 |
Why?
|
| Interleukin-1alpha | 1 | 2014 | 84 | 0.120 |
Why?
|
| U937 Cells | 1 | 2014 | 268 | 0.120 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 193 | 0.110 |
Why?
|
| Cell Respiration | 1 | 2014 | 201 | 0.110 |
Why?
|
| Gases | 1 | 2014 | 197 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1678 | 0.110 |
Why?
|
| Co-Repressor Proteins | 1 | 2014 | 194 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 1369 | 0.110 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 137 | 0.110 |
Why?
|
| Models, Immunological | 1 | 2015 | 527 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 697 | 0.110 |
Why?
|
| Endotoxins | 2 | 2014 | 527 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2008 | 3523 | 0.110 |
Why?
|
| Cell Death | 2 | 2016 | 1706 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 5867 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 504 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 393 | 0.110 |
Why?
|
| Male | 14 | 2022 | 350118 | 0.110 |
Why?
|
| Reperfusion Injury | 4 | 2012 | 1026 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2017 | 1726 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 16365 | 0.100 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 2077 | 0.100 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 677 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 430 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 617 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2635 | 0.100 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 612 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2014 | 558 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2019 | 2751 | 0.100 |
Why?
|
| Acetylation | 1 | 2014 | 1085 | 0.100 |
Why?
|
| Cadherins | 1 | 2015 | 907 | 0.090 |
Why?
|
| Delayed Graft Function | 1 | 2010 | 48 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 903 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 720 | 0.090 |
Why?
|
| Potassium | 1 | 2014 | 1336 | 0.090 |
Why?
|
| Protoporphyrins | 2 | 2012 | 164 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 317 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 443 | 0.090 |
Why?
|
| Microtubules | 1 | 2016 | 1090 | 0.090 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2009 | 29 | 0.090 |
Why?
|
| Cytoprotection | 2 | 2007 | 210 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3870 | 0.090 |
Why?
|
| Cytosine Deaminase | 1 | 2009 | 68 | 0.090 |
Why?
|
| Sepsis | 2 | 2014 | 2593 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 635 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 728 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3278 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2014 | 1539 | 0.080 |
Why?
|
| Interleukin-10 | 3 | 2009 | 1200 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 241 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 123 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 2216 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 547 | 0.080 |
Why?
|
| Gene Expression | 1 | 2021 | 7799 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2025 | 0.080 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2008 | 96 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1783 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1119 | 0.070 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2007 | 171 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2013 | 3128 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1511 | 0.070 |
Why?
|
| Mice, Nude | 1 | 2013 | 3689 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2009 | 627 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 594 | 0.070 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2007 | 124 | 0.070 |
Why?
|
| Rats | 3 | 2014 | 24260 | 0.070 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 92 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5172 | 0.070 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2008 | 337 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 4445 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1477 | 0.070 |
Why?
|
| Iron | 1 | 2014 | 1774 | 0.070 |
Why?
|
| Cobalt | 1 | 2005 | 158 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 893 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2014 | 2504 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 638 | 0.060 |
Why?
|
| Mitochondria | 3 | 2014 | 3520 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4204 | 0.060 |
Why?
|
| Autophagy | 1 | 2012 | 1300 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.060 |
Why?
|
| Biopsy | 1 | 2016 | 6756 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5256 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2008 | 3002 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 11366 | 0.060 |
Why?
|
| Photochemotherapy | 1 | 2009 | 807 | 0.060 |
Why?
|
| Models, Animal | 1 | 2010 | 2171 | 0.060 |
Why?
|
| Plasmids | 1 | 2008 | 2307 | 0.050 |
Why?
|
| Wound Healing | 1 | 2014 | 2785 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2005 | 690 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 1142 | 0.050 |
Why?
|
| Adenosine | 1 | 2007 | 825 | 0.050 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13695 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3701 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 8301 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5021 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 2892 | 0.050 |
Why?
|
| Cell Survival | 2 | 2008 | 5882 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2010 | 1580 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3505 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.050 |
Why?
|
| Time Factors | 2 | 2014 | 40075 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1504 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 15997 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 648 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 2382 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1790 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 6895 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2021 | 936 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2008 | 13033 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2008 | 2948 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 1351 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5221 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2007 | 1139 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2021 | 826 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18029 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 985 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 893 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2021 | 1152 | 0.030 |
Why?
|
| Liver | 1 | 2011 | 7474 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2006 | 1537 | 0.030 |
Why?
|
| Models, Biological | 2 | 2009 | 9583 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 4262 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 701 | 0.030 |
Why?
|
| Oncogenes | 1 | 2021 | 1265 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 4251 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5751 | 0.030 |
Why?
|
| Sumoylation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Base Sequence | 1 | 2005 | 12797 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3557 | 0.030 |
Why?
|
| Antioxidants | 2 | 2014 | 1663 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 905 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 169 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 835 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2934 | 0.020 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 66 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 665 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2916 | 0.020 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1634 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 417 | 0.020 |
Why?
|
| Tyrosine | 1 | 2014 | 1461 | 0.020 |
Why?
|
| Flucytosine | 1 | 2009 | 32 | 0.020 |
Why?
|
| Antimetabolites | 1 | 2009 | 125 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2014 | 1959 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 528 | 0.020 |
Why?
|
| Receptors, Purinergic | 1 | 2009 | 66 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
| Lung | 3 | 2016 | 9856 | 0.020 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2007 | 15 | 0.020 |
Why?
|
| Prodrugs | 1 | 2009 | 268 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 1990 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 1086 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2010 | 743 | 0.020 |
Why?
|
| Nucleotides | 1 | 2009 | 464 | 0.020 |
Why?
|
| Graft Rejection | 2 | 2010 | 4397 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 2689 | 0.020 |
Why?
|
| Angiogenic Proteins | 1 | 2006 | 104 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2007 | 596 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2006 | 277 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2006 | 198 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1564 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6622 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 534 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2007 | 579 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 675 | 0.020 |
Why?
|
| Female | 2 | 2021 | 380194 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6364 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2007 | 1899 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 57776 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 597 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12208 | 0.010 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 745 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2915 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5179 | 0.010 |
Why?
|
| Pyridines | 1 | 2012 | 2825 | 0.010 |
Why?
|
| Swine | 1 | 2010 | 5917 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15165 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 4776 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 2007 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 2889 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1912 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2006 | 4199 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 163280 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4420 | 0.010 |
Why?
|
| Oxygen | 1 | 2007 | 4189 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 7186 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9438 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 7913 | 0.010 |
Why?
|